190 related articles for article (PubMed ID: 26459663)
1. The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans.
Shao J; Zhang M; Wang T; Li Y; Wang C
Pharm Biol; 2016; 54(6):984-92. PubMed ID: 26459663
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of the overexpression of the ERG-11, MDR-1, CDR-1, and CDR-2 genes in fluconazole-resistant Candida albicans isolated from Ahvazian cancer patients with oral candidiasis.
Maheronnaghsh M; Teimoori A; Dehghan P; Fatahinia M
J Clin Lab Anal; 2022 Feb; 36(2):e24208. PubMed ID: 34997991
[TBL] [Abstract][Full Text] [Related]
3. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of the expression levels of efflux pumps in fluconazole-resistant Candida albicans isolates].
Gulat S; Doluca Dereli M
Mikrobiyol Bul; 2014 Apr; 48(2):325-34. PubMed ID: 24819270
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
Kalkandelen KT; Doluca Dereli M
Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
[TBL] [Abstract][Full Text] [Related]
6. Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions.
Shao J; Cui Y; Zhang M; Wang T; Wu D; Wang C
Pharm Biol; 2017 Dec; 55(1):355-359. PubMed ID: 27931143
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.
Zhang H; Gao A; Li F; Zhang G; Ho HI; Liao W
Yakugaku Zasshi; 2009 May; 129(5):623-30. PubMed ID: 19420894
[TBL] [Abstract][Full Text] [Related]
8. [Function and gene expression of the active efflux transporters in drug-resistant Candida albicans].
Guo HJ; Xia ZD; Wu GL; Zhou H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):183-7. PubMed ID: 17344615
[TBL] [Abstract][Full Text] [Related]
9. Resensitization of Fluconazole-Resistant Urinary
Edward EA; Mohamed NM; Zakaria AS
Pol J Microbiol; 2020 Sep; 69(1):73-84. PubMed ID: 32189482
[TBL] [Abstract][Full Text] [Related]
10. Eucalyptal D Enhances the Antifungal Effect of Fluconazole on Fluconazole-Resistant
Xu J; Liu R; Sun F; An L; Shang Z; Kong L; Yang M
Front Cell Infect Microbiol; 2019; 9():211. PubMed ID: 31281800
[TBL] [Abstract][Full Text] [Related]
11. Investigation of fluconazole susceptibility to Candida albicans by MALDI-TOF MS and real-time PCR for CDR1, CDR2, MDR1 and ERG11.
Maenchantrarath C; Khumdee P; Samosornsuk S; Mungkornkaew N; Samosornsuk W
BMC Microbiol; 2022 Jun; 22(1):153. PubMed ID: 35689195
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
[TBL] [Abstract][Full Text] [Related]
13. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
Khajeh E; Hosseini Shokouh SJ; Rajabibazl M; Roudbary M; Rafiei S; Aslani P; Farahnejad Z
Br J Biomed Sci; 2016; 73(1):44-8. PubMed ID: 27182677
[TBL] [Abstract][Full Text] [Related]
14. Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of
Černáková L; Dižová S; Gášková D; Jančíková I; Bujdáková H
Microb Drug Resist; 2019; 25(6):805-812. PubMed ID: 30785845
[No Abstract] [Full Text] [Related]
15. ABC transporter Cdr1p contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates.
Holmes AR; Lin YH; Niimi K; Lamping E; Keniya M; Niimi M; Tanabe K; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2008 Nov; 52(11):3851-62. PubMed ID: 18710914
[TBL] [Abstract][Full Text] [Related]
16. Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.
Yu LH; Wei X; Ma M; Chen XJ; Xu SB
Antimicrob Agents Chemother; 2012 Feb; 56(2):770-5. PubMed ID: 22106223
[TBL] [Abstract][Full Text] [Related]
17. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
Sun LM; Liao K; Liang S; Yu PH; Wang DY
J Appl Microbiol; 2015 Apr; 118(4):826-38. PubMed ID: 25641229
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans.
Zhang X; Guo H; Gao L; Song Y; Li S; Zhang H
Pharm Biol; 2013 Jun; 51(6):749-52. PubMed ID: 23527892
[TBL] [Abstract][Full Text] [Related]
20. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.
Saibabu V; Fatima Z; Singh S; Khan LA; Hameed S
J Mycol Med; 2020 Apr; 30(1):100921. PubMed ID: 31937429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
